Literature DB >> 11713219

Tyrosine phosphorylation-dependent and -independent role of Shc in the regulation of IGF-1-induced mitogenesis and glycogen synthesis.

T Sasaoka1, M Ishiki, T Wada, H Hori, H Hirai, T Haruta, H Ishihara, M Kobayashi.   

Abstract

To examine the functional role of Shc tyrosine phosphorylation in IGF-1 signaling, wild-type (WT)-Shc and Y239,240,317F (3F)-Shc were transiently transfected into L6 myoblasts. IGF-1 signaling was compared among the transfected cells. IGF-1-induced tyrosine phosphorylation of Shc and its subsequent association with Grb2 were increased in WT-Shc cells, whereas they were decreased in 3F-Shc cells compared with those in parental L6 cells. Consistent with their changes, IGF-1-induced MAPK activation and thymidine incorporation were enhanced in WT-Shc cells, whereas they were again decreased in 3F-Shc cells. It is possible that Shc and insulin receptor substrate (IRS)-1 can interact competitively, via their phosphotyrosine binding (PTB) domains, with the activated IGF-1 receptor. In this regard, IGF-1-induced tyrosine phosphorylation of IRS-1 was decreased by overexpressing both WT-Shc and 3F-Shc cells. Consistent with the decrease, IGF-1-induced IRS-1 association with the p85 subunit of PI3K and activation of PI3K and Akt were reduced in both WT-Shc and 3F-Shc cells. As a result, IGF-1-induced glycogen synthesis was also decreased in both cells. Furthermore, expression of Shc PTB domain alone inhibited IGF-1 stimulation of Akt and glycogen synthesis. These results indicate that tyrosine phosphorylation of Shc is important for IGF-1 stimulation of MAPK leading to mitogenesis and that Shc, via its PTB domain, negatively regulates IGF-1-induced glycogen synthesis by competing with IRS-1, which is not relevant to Shc tyrosine phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11713219     DOI: 10.1210/endo.142.12.8543

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  12 in total

1.  Hyperglycemia-induced p66shc inhibits insulin-like growth factor I-dependent cell survival via impairment of Src kinase-mediated phosphoinositide-3 kinase/AKT activation in vascular smooth muscle cells.

Authors:  Gang Xi; Xinchun Shen; Yashwanth Radhakrishnan; Laura Maile; David Clemmons
Journal:  Endocrinology       Date:  2010-06-09       Impact factor: 4.736

2.  α6 integrin transactivates insulin-like growth factor receptor-1 (IGF-1R) to regulate caspase-3-mediated lens epithelial cell differentiation initiation.

Authors:  Subhasree Basu; Suren Rajakaruna; Adèle De Arcangelis; Liping Zhang; Elisabeth Georges-Labouesse; A Sue Menko
Journal:  J Biol Chem       Date:  2013-12-31       Impact factor: 5.157

3.  Motor neurone targeting of IGF-1 prevents specific force decline in ageing mouse muscle.

Authors:  Anthony M Payne; Zhenlin Zheng; María Laura Messi; Carol E Milligan; Estela González; Osvaldo Delbono
Journal:  J Physiol       Date:  2005-11-17       Impact factor: 5.182

4.  Recruitment of Pyk2 to SHPS-1 signaling complex is required for IGF-I-dependent mitogenic signaling in vascular smooth muscle cells.

Authors:  Xinchun Shen; Gang Xi; Yashwanth Radhakrishnan; David R Clemmons
Journal:  Cell Mol Life Sci       Date:  2010-06-03       Impact factor: 9.261

5.  Role of SHPS-1 in the regulation of insulin-like growth factor I-stimulated Shc and mitogen-activated protein kinase activation in vascular smooth muscle cells.

Authors:  Yan Ling; Laura A Maile; Jaroslava Lieskovska; Jane Badley-Clarke; David R Clemmons
Journal:  Mol Biol Cell       Date:  2005-05-11       Impact factor: 4.138

6.  The proximal signaling network of the BCR-ABL1 oncogene shows a modular organization.

Authors:  B Titz; T Low; E Komisopoulou; S S Chen; L Rubbi; T G Graeber
Journal:  Oncogene       Date:  2010-08-09       Impact factor: 9.867

7.  p66shc negatively regulates insulin-like growth factor I signal transduction via inhibition of p52shc binding to Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 leading to impaired growth factor receptor-bound protein-2 membrane recruitment.

Authors:  Gang Xi; Xinchun Shen; David R Clemmons
Journal:  Mol Endocrinol       Date:  2008-07-07

8.  Insulin-like growth factor-I stimulates Shc-dependent phosphatidylinositol 3-kinase activation via Grb2-associated p85 in vascular smooth muscle cells.

Authors:  Yashwanth Radhakrishnan; Laura A Maile; Yan Ling; Lee M Graves; David R Clemmons
Journal:  J Biol Chem       Date:  2008-04-16       Impact factor: 5.157

9.  p66shc inhibits insulin-like growth factor-I signaling via direct binding to Src through its polyproline and Src homology 2 domains, resulting in impairment of Src kinase activation.

Authors:  Gang Xi; Xinchun Shen; David R Clemmons
Journal:  J Biol Chem       Date:  2010-01-04       Impact factor: 5.157

10.  Growth hormone, insulin-like growth factor 1, and insulin signaling-a pharmacological target in body wasting and cachexia.

Authors:  Katja Trobec; Stephan von Haehling; Stefan D Anker; Mitja Lainscak
Journal:  J Cachexia Sarcopenia Muscle       Date:  2011-10-20       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.